WOBURN, Mass.-CardioTech International Inc. has completed the first phase of testing on its CardioPass synthetic coronary artery bypass graft, a product it claims has a potential market of $1.5 ...

Medical devices maker CardioTech International Inc. plans to acquire Gish Biomedical Inc. for about $7.6 million in stock. The move significantly will expand Woburn, Mass.-based CardioTech's presence ...

Medical device maker CardioTech International Inc., which makes products to treat late-stage cardiovascular disease, announced that it canceled its planned acquisition of CarTika Medical Inc. on June ...

Wilmington's CardioTech International Inc., a developer and manufacturer of medical devices, has executed on a definitive agreement to acquire CarTika Medical Inc., a private medical device contract ...

A tripling in sales during the last fiscal year has spurred CardioTech International Inc. into expanding a major portion of its four-division, three-plant operation. The urethane medical device maker ...

CardioTech's clinical end points are patient survivability, quality of life, freedom from angina, and graft patency. Dr. Michael Szycher, CEO and Chairman, CardioTech, said, "The Company is embarking ...

Medical device manufacturer CardioTech International Inc. has bought a plastics-oriented contract manufacturer, CarTika Medical Inc., for $6.6 million. Publicly traded CardioTech of Wilmington, Mass., ...

CardioTech International may well become known as the pride of Wilmington. Headquartered in Wilmington, the company develops and markets medical devices used in the treatment of late stage ...

CardioTech International Inc., a medical device developer and manufacturer, acquired Plymouth-based CarTika Medical Inc., a privately held medical device contract manufacturer. Terms of the deal were ...

The Wall Street Transcript is a completely unique resource for investors and business researchers.